دورية أكاديمية
Clinical efficacy of complex antioxidant therapy for pelvic varicose veins in women: A prospective non-randomized controlled study
| العنوان: | Clinical efficacy of complex antioxidant therapy for pelvic varicose veins in women: A prospective non-randomized controlled study |
|---|---|
| المؤلفون: | Dmitry A. Stupin, Lyubov I. Kolesnikova, Andrey A. Semendyaev, Marina A. Darenskaya, Daria V. Tukhieva, Ekaterina S. Bystrova, Ksenia V. Kuryshova, Aleksandr I. Gus |
| المصدر: | Гинекология, Vol 26, Iss 1, Pp 52-58 (2024) |
| بيانات النشر: | IP Berlin A.V., 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Gynecology and obstetrics |
| مصطلحات موضوعية: | pelvic varicose veins, pro- and antioxidant status, antioxidant complex, regional vein hemodynamics, quality of life, Gynecology and obstetrics, RG1-991 |
| الوصف: | Aim. To evaluate the clinical efficacy of complex antioxidant therapy (CAT) in the treatment of patients with pelvic varicose veins (PVV). Materials and methods. Patients with PVV (n=150) were divided into groups 1 and 2 of 75 subjects; the groups were comparable. Treatment in both groups included standard therapy with one of the venotropic agents (60 days). Patients of group 1 additionally received CAT for 30 days (1 course), in total 3 courses with 2-month intervals. Results. When assessing the parameters of the lipoperoxidation system (antioxidant protection) in group 1 during CAT combined with standard venotropic therapy, there was a statistically significant decrease in the levels of lipid hydroperoxides (p0.0001), diene conjugates (p=0.001), malonic dialdehyde (p0.0001), an increase in the levels of catalase (p0.0001), superoxide dismutase (p0.0001), glutathione peroxidase (p0.0001), glutathione reductase (p0.0001), glutathione-S-transferase (p=0.002) and the reduced glutathione content (p=0.032) compared to levels before treatment. The above group showed a decrease in the diameter of the pelvic varicose veins: internal iliac (p0.001), ovarian (p0.0001) and arcuate (p0.001), an increase in their blood flow velocity (p=0.003, 0.041, and 0.040, respectively), a decrease in the duration of retrograde flow to 0.3 cm. There was a decrease in pelvic pain (p0.0001), dysmenorrhea (p=0.024), dyspareunia (p=0.037), the frequency of irregular menstruation (p=0.031), an improvement in quality of life (p=0.047), pregnancy rate (p=0.013), the number of live births (p=0.004), and the duration of remission (p=0.047). Conclusion. The use of a combination of antioxidants superoxide dismutase 250 mg 2 times a day, acetyl-glutathione at 100 mg 2 times a day, and astaxanthin 400 mg/day for 30 days in 3 courses with 2-month intervals combined with venotropic therapy can significantly improve the treatment outcomes of patients with PVV. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | Russian |
| تدمد: | 2079-5696 2079-5831 20795696 |
| العلاقة: | https://gynecology.orscience.ru/2079-5831/article/viewFile/631813/147184Test; https://doaj.org/toc/2079-5696Test; https://doaj.org/toc/2079-5831Test |
| DOI: | 10.26442/20795696.2024.1.202556 |
| الوصول الحر: | https://doaj.org/article/c0ea2c728fe44e8ab5d665641dd322a0Test |
| رقم الانضمام: | edsdoj.0ea2c728fe44e8ab5d665641dd322a0 |
| قاعدة البيانات: | Directory of Open Access Journals |
| تدمد: | 20795696 20795831 |
|---|---|
| DOI: | 10.26442/20795696.2024.1.202556 |